Dual-Energy x-ray absorptiometry in the early diagnosis of body shape changes in patients with HIV infection treated with nucleoside reverse transcriptase inhibitors and naive to protease inhibitors

Suttmann, 1995, Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus infected outpatients, J Acquired Immune Defic Syndr Hum Retrovirol, 8, 239, 10.1097/00042560-199503010-00004 Kotler, 1989, Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS, Am J Clin Nutr., 50, 444, 10.1093/ajcn/50.3.444 Shor-Posner, 1993, Hypocholesterolemia is associated with immunodysfunction in early human immunodeficiency virus-1 infection, Am J Med., 94, 515, 10.1016/0002-9343(93)90087-6 Grunfeld, 1989, Hypertriglyceridemia in acquired immunodeficiency syndrome, Am J Med., 86, 27, 10.1016/0002-9343(89)90225-8 Melchior, 1991, Resting energy expenditure is increased in stable, malnourished HIV-infected patients, Am J Clin Nutr., 53, 437, 10.1093/ajcn/53.2.437 Carr, 1999, Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study, Lancet, 353, 2093, 10.1016/S0140-6736(98)08468-2 Behrens, 26281999, Lipid abnormalities in HIV-1 positive patients treated with protease inhibitors., Presented at: First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV Gharakhanian, 3141999, Frequency of lipodystrophy and factors associated with glucose/lipid abnormalities in a cohort of 650 patients treated with protease inhibitors, Presented at: Sixth Conference on Retroviruses and Opportunistic Infections Slosman, 1992, Assessment of whole-body composition with dual-energy x-ray absorptiometry, Radiology, 185, 593, 10.1148/radiology.185.2.1410379 1992, 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR Morb Mortal Wkly Rep, 41, 1 Kotler, 1985, Body composition studies in patients with the acquired immunodeficiency syndrome, Am J Clin Nutr, 42, 1255, 10.1093/ajcn/42.6.1255 Paton, 1997, Bone mineral density in patients with human immunodeficiency virus infection, Calcif Tissue Int, 61, 30, 10.1007/s002239900288 Mellert, 1990, Infection of human fibroblast and osteoblast-like cells with HIV-1, AIDS, 4, 527, 10.1097/00002030-199006000-00006 Constans, 1994, Plasma lipids in HIV-infected patients: A prospective study in 95 patients, Eur J Clin Invest, 24, 416, 10.1111/j.1365-2362.1994.tb02185.x Saint-Marc, 3141999, A syndrome of lipodystrophy in patients receiving a stable nucleoside-analogue therapy, Presented at: Sixth Conference on Retroviruses and Opportunistic Infections Madge, 3141999, Lipodystrophy syndrome (LS) in patients on reverse transcriptase inhibitors, Presented at: Sixth Conference on Retroviruses and Opportunities Infections Boxwell, 26291999, Lactic acidosis (LA) in patients receiving nucleoside reverse transcriptase inhibitors (NRTIs), Presented at: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy Gervasoni, 3141999, Nucleoside reverse transcriptase inhibitors associated fat redistribution in HIV-infected women undergoing combined antiretroviral therapy, Presented at: Sixth Conference on Retroviruses and Opportunistic Infections